COMPASS Pathways Balance Sheet Health
Financial Health criteria checks 5/6
COMPASS Pathways has a total shareholder equity of $225.7M and total debt of $28.8M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are $276.0M and $50.2M respectively.
Key information
12.7%
Debt to equity ratio
US$28.76m
Debt
| Interest coverage ratio | n/a |
| Cash | US$220.20m |
| Equity | US$225.74m |
| Total liabilities | US$50.24m |
| Total assets | US$275.99m |
Recent financial health updates
Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06
Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25Recent updates
COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15Compass Pathways: Huge Growth Potential, But I'm Cautious
Jun 04COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25COMPASS Pathways raises $144M capital via equity offering
Apr 30COMPASS Pathways launches public offering
Apr 27We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate
Feb 08Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
Jan 01Compass Pathways: Risky And Overvalued
Dec 18What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?
Dec 18COMPASS Pathways: Risky But Can Pay Back Generously
Dec 14Compass Pathways: An Overvalued Psychedelic Company With A Single Mediocre Drug
Nov 23COMPASS Pathways ADS reports Q3 results
Nov 12Financial Position Analysis
Short Term Liabilities: CMPS's short term assets ($261.3M) exceed its short term liabilities ($19.6M).
Long Term Liabilities: CMPS's short term assets ($261.3M) exceed its long term liabilities ($30.6M).
Debt to Equity History and Analysis
Debt Level: CMPS has more cash than its total debt.
Reducing Debt: CMPS's debt to equity ratio has increased from 0% to 12.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CMPS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CMPS has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 37.7% each year.